TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above? - Di Giovanni G; De Deurwaerdère P. (2017)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com